{
    "clinical_study": {
        "@rank": "112480", 
        "arm_group": [
            {
                "arm_group_label": "Lactated Ringer's solution", 
                "arm_group_type": "Active Comparator", 
                "description": "Lactated Ringer's solution of 1500 ml will be used as a pump-priming solution during cardiac surgery."
            }, 
            {
                "arm_group_label": "Volulyte", 
                "arm_group_type": "Experimental", 
                "description": "Lactated Ringer's solution of 500 ml with Hydroxyethyl Starch 6% 130/0.4 (Volulyte, Fresenius Kabi, Germany) of 1000 ml will be used as a pump-priming solution during cardiac surgery."
            }, 
            {
                "arm_group_label": "Hextend", 
                "arm_group_type": "Experimental", 
                "description": "Lactated Ringer's solution of 500 ml with Hextend (BioTime Inc., Berkerley, CA) of 1000 ml will be used as a pump-priming solution during cardiac surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effects of crystalloid and colloid, which are\n      used for pump priming solution, on the microcirculatory alterations during cardiac surgery."
        }, 
        "brief_title": "Effects of Colloid and Crystalloid on the Microcirculatory Alterations During Off-pump Coronary Artery Bypass Surgery", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cardiac Surgery", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Valvular heart surgery\n\n        Exclusion Criteria:\n\n          -  Infection\n\n          -  Postoperative use of steroid\n\n          -  Liver cirrhosis, Child-Pugh C\n\n          -  Renal disease on hemodialysis\n\n          -  Patients who cannot receive vascular occlusion test (severe peripheral vascular\n             disease, arteriovenous fistula, burn)\n\n          -  EF < 40% on the preoperative echocardiography\n\n          -  Preoperative use of vasopressors or inotropic agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "93", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01713166", 
            "org_study_id": "YSJeon_crystalloid vs colloid"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lactated Ringer's solution", 
                "description": "Lactated Ringer's solution of 1500 ml will be used as a pump-priming solution during cardiac surgery.", 
                "intervention_name": "Lactated Ringer's solution", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Volulyte", 
                "description": "Lactated Ringer's solution of 500 ml with Hydroxyethyl Starch 6% 130/0.4 (Volulyte, Fresenius Kabi, Germany) of 1000 ml will be used as a pump-priming solution during cardiac surgery.", 
                "intervention_name": "Volulyte", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Hextend", 
                "description": "Lactated Ringer's solution of 500 ml with Hextend (BioTime Inc., Berkerley, CA) of 1000 ml will be used as a pump-priming solution during cardiac surgery.", 
                "intervention_name": "Hextend", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hetastarch"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "contact": {
                "email": "jeonyunseok@gmail.com", 
                "last_name": "Yunseok Jeon, PhD", 
                "phone": "82-2-2072-2467"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "jeonyunseok@gmail.com", 
            "last_name": "Yunseok Jeon, PhD", 
            "phone": "82-2-2072-2467"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Recovery slope is a marker of microcirculation. The tissue oxygen saturation (StO2) using InspectraTM StO2 (Hutchinson Technology Inc.,USA) will be recorded continuously. The InspectraTM StO2 probe will be placed on the skin of the thenar eminence and the blood pressure cuff will be wrapped around the arm. After performing vascular occlusion test, the recovery slope will be calculated by the software.", 
                "measure": "Recovery slope", 
                "safety_issue": "Yes", 
                "time_frame": "until 2 days after surgery"
            }, 
            {
                "description": "Recovery slope is a marker of microcirculation. The tissue oxygen saturation (StO2) using InspectraTM StO2 (Hutchinson Technology Inc., USA) will be recorded continuously. The InspectraTM StO2 probe will be placed on the skin of the thenar eminence and the blood pressure cuff will be wrapped around the arm. After performing vascular occlusion test, the recovery slope will be calculated by the software.", 
                "measure": "Recovery slope", 
                "safety_issue": "Yes", 
                "time_frame": "until 2 days after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01713166"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Yunseok Jeon", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "lactate", 
                "safety_issue": "No", 
                "time_frame": "until 2 days after surgery"
            }, 
            {
                "measure": "StO2 (tissue oxygen saturation)", 
                "safety_issue": "Yes", 
                "time_frame": "until 2 days after surgery"
            }, 
            {
                "description": "Interleukin (IL)-1b, IL-6, IL-8, IL-10, TNF-a", 
                "measure": "Cytokine", 
                "safety_issue": "No", 
                "time_frame": "until 2 days after surgery"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}